Does CRESTOR Cause Off label use? 60 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Off label use have been filed in association with CRESTOR. This represents 5.0% of all adverse event reports for CRESTOR.
60
Reports of Off label use with CRESTOR
5.0%
of all CRESTOR reports
2
Deaths
25
Hospitalizations
How Dangerous Is Off label use From CRESTOR?
Of the 60 reports, 2 (3.3%) resulted in death, 25 (41.7%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRESTOR. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does CRESTOR Cause?
Type 2 diabetes mellitus (342)
Cardiovascular disorder (319)
Myocardial infarction (135)
Myalgia (87)
Drug dose omission (83)
Blood cholesterol increased (75)
Drug hypersensitivity (51)
Intentional product misuse (49)
Drug ineffective (48)
Malaise (48)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CRESTOR Alternatives Have Lower Off label use Risk?
CRESTOR vs CRISABOROLE
CRESTOR vs CRIZANLIZUMAB
CRESTOR vs CRIZANLIZUMAB-TMCA
CRESTOR vs CRIZOTINIB
CRESTOR vs CROFELEMER